A novel spider peptide toxin suppresses tumor growth through dual signaling pathways

Z. Liu, M. Deng, J. Xiang, H. Ma, W. Hu, Y. Zhao, D. W.C. Li, S. Liang

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Spider venom is a large pharmacological repertoire containing many biologically active peptides, which may have a potent therapeutic implication. Here we investigated a peptide toxin, named lycosin-I, isolated from the venom of the spider Lycosa singoriensis. In contrast to most spider peptide toxins adopting inhibitor cystine knot (ICK) motif, lycosin-I shows a linear amphipathic alpha-helical conformation, common to α-helical host defense peptides. Lycosin-I displays strong ability to inhibit cancer cell growth in vitro and can effectively suppresses tumor growth in vivo. Mechanistically, it activates the mitochondrial death pathway to sensitize cancer cells for apoptosis, as well as up-regulates p27 to inhibit cell proliferation. Taken together, our results provide the first evidence that a spider toxin can effectively suppress tumorigenesis through activation of dual signaling pathways. In addition, lycosin-I may be a useful structural lead for the development of novel anticancer drugs.

Original languageEnglish (US)
Pages (from-to)1350-1360
Number of pages11
JournalCurrent Molecular Medicine
Volume12
Issue number10
DOIs
StatePublished - Dec 3 2012

Fingerprint

Spiders
Tumors
Spider Venoms
Peptides
Growth
Cystine Knot Motifs
Neoplasms
Cystine
Cell proliferation
Cell growth
Conformations
Carcinogenesis
Up-Regulation
Chemical activation
Cells
Cell Proliferation
Pharmacology
Apoptosis
Pharmaceutical Preparations
Therapeutics

Keywords

  • Apoptosis
  • Cell proliferation
  • Gene expression
  • Mitochondria
  • P27
  • Signal transduction
  • Spider peptide toxin
  • Tumor suppression

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

A novel spider peptide toxin suppresses tumor growth through dual signaling pathways. / Liu, Z.; Deng, M.; Xiang, J.; Ma, H.; Hu, W.; Zhao, Y.; Li, D. W.C.; Liang, S.

In: Current Molecular Medicine, Vol. 12, No. 10, 03.12.2012, p. 1350-1360.

Research output: Contribution to journalArticle

Liu, Z, Deng, M, Xiang, J, Ma, H, Hu, W, Zhao, Y, Li, DWC & Liang, S 2012, 'A novel spider peptide toxin suppresses tumor growth through dual signaling pathways', Current Molecular Medicine, vol. 12, no. 10, pp. 1350-1360. https://doi.org/10.2174/156652412803833643
Liu, Z. ; Deng, M. ; Xiang, J. ; Ma, H. ; Hu, W. ; Zhao, Y. ; Li, D. W.C. ; Liang, S. / A novel spider peptide toxin suppresses tumor growth through dual signaling pathways. In: Current Molecular Medicine. 2012 ; Vol. 12, No. 10. pp. 1350-1360.
@article{93c7334f3bac41a999efced76be74926,
title = "A novel spider peptide toxin suppresses tumor growth through dual signaling pathways",
abstract = "Spider venom is a large pharmacological repertoire containing many biologically active peptides, which may have a potent therapeutic implication. Here we investigated a peptide toxin, named lycosin-I, isolated from the venom of the spider Lycosa singoriensis. In contrast to most spider peptide toxins adopting inhibitor cystine knot (ICK) motif, lycosin-I shows a linear amphipathic alpha-helical conformation, common to α-helical host defense peptides. Lycosin-I displays strong ability to inhibit cancer cell growth in vitro and can effectively suppresses tumor growth in vivo. Mechanistically, it activates the mitochondrial death pathway to sensitize cancer cells for apoptosis, as well as up-regulates p27 to inhibit cell proliferation. Taken together, our results provide the first evidence that a spider toxin can effectively suppress tumorigenesis through activation of dual signaling pathways. In addition, lycosin-I may be a useful structural lead for the development of novel anticancer drugs.",
keywords = "Apoptosis, Cell proliferation, Gene expression, Mitochondria, P27, Signal transduction, Spider peptide toxin, Tumor suppression",
author = "Z. Liu and M. Deng and J. Xiang and H. Ma and W. Hu and Y. Zhao and Li, {D. W.C.} and S. Liang",
year = "2012",
month = "12",
day = "3",
doi = "10.2174/156652412803833643",
language = "English (US)",
volume = "12",
pages = "1350--1360",
journal = "Current Molecular Medicine",
issn = "1566-5240",
publisher = "Bentham Science Publishers B.V.",
number = "10",

}

TY - JOUR

T1 - A novel spider peptide toxin suppresses tumor growth through dual signaling pathways

AU - Liu, Z.

AU - Deng, M.

AU - Xiang, J.

AU - Ma, H.

AU - Hu, W.

AU - Zhao, Y.

AU - Li, D. W.C.

AU - Liang, S.

PY - 2012/12/3

Y1 - 2012/12/3

N2 - Spider venom is a large pharmacological repertoire containing many biologically active peptides, which may have a potent therapeutic implication. Here we investigated a peptide toxin, named lycosin-I, isolated from the venom of the spider Lycosa singoriensis. In contrast to most spider peptide toxins adopting inhibitor cystine knot (ICK) motif, lycosin-I shows a linear amphipathic alpha-helical conformation, common to α-helical host defense peptides. Lycosin-I displays strong ability to inhibit cancer cell growth in vitro and can effectively suppresses tumor growth in vivo. Mechanistically, it activates the mitochondrial death pathway to sensitize cancer cells for apoptosis, as well as up-regulates p27 to inhibit cell proliferation. Taken together, our results provide the first evidence that a spider toxin can effectively suppress tumorigenesis through activation of dual signaling pathways. In addition, lycosin-I may be a useful structural lead for the development of novel anticancer drugs.

AB - Spider venom is a large pharmacological repertoire containing many biologically active peptides, which may have a potent therapeutic implication. Here we investigated a peptide toxin, named lycosin-I, isolated from the venom of the spider Lycosa singoriensis. In contrast to most spider peptide toxins adopting inhibitor cystine knot (ICK) motif, lycosin-I shows a linear amphipathic alpha-helical conformation, common to α-helical host defense peptides. Lycosin-I displays strong ability to inhibit cancer cell growth in vitro and can effectively suppresses tumor growth in vivo. Mechanistically, it activates the mitochondrial death pathway to sensitize cancer cells for apoptosis, as well as up-regulates p27 to inhibit cell proliferation. Taken together, our results provide the first evidence that a spider toxin can effectively suppress tumorigenesis through activation of dual signaling pathways. In addition, lycosin-I may be a useful structural lead for the development of novel anticancer drugs.

KW - Apoptosis

KW - Cell proliferation

KW - Gene expression

KW - Mitochondria

KW - P27

KW - Signal transduction

KW - Spider peptide toxin

KW - Tumor suppression

UR - http://www.scopus.com/inward/record.url?scp=84870187949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870187949&partnerID=8YFLogxK

U2 - 10.2174/156652412803833643

DO - 10.2174/156652412803833643

M3 - Article

C2 - 22882120

AN - SCOPUS:84870187949

VL - 12

SP - 1350

EP - 1360

JO - Current Molecular Medicine

JF - Current Molecular Medicine

SN - 1566-5240

IS - 10

ER -